VERA Vera Therapeutics, Inc. - Class A Common Stock
$34,27
السعر · مايو 20, 2026
البيانات الأساسية اعتبارًا من مايو 7, 2026
نطاق 52 أسبوعًا
$19–$56
42% of range
تقييم المحللين
BUY
20 analysts
السعر المستهدف
$79
+129% upside
P/E (TTM)
-10.9
ROE
-55.9%
هامش صافي الربح
—
VERA لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$34.27
القيمة السوقية
—
P/E (TTM)
-10.9
ربح السهم (آخر 12 شهرًا)
$-4.66
الإيرادات (آخر 12 شهرًا)
—
عائد التوزيعات
—
ROE
-55.9%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$19 – $56
VERA مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
—
ربح السهم
$-4.66
2021-12-31
→
2025-12-31
التدفق النقدي الحر
$-242M
2022-12-31
→
2025-12-31
الهوامش
—
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
VERA
متوسط الأقران
P/E (TTM)
-10.9
28.7
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
VERA
متوسط الأقران
ROA (العائد على الأصول)
-43.1%
-24.1%
ROE
-55.9%
-33.3%
ROIC
-52.2%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
VERA
متوسط الأقران
Current Ratio (النسبة الحالية)
13.6
12.3
Quick Ratio (النسبة السريعة)
13.4
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
VERA
متوسط الأقران
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
VERA
متوسط الأقران
VERA توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
20 محللين
- شراء قوي 7 35,0%
- شراء 11 55,0%
- احتفاظ 2 10,0%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
14 محللين · 2026-05-14
الوسيط
$83.00
← أقل من جميع الأهداف
$34.27
منخفض
$35.00
مرتفع
$110.00
السعر المستهدف الوسيط
$83.00
+142,2%
السعر المستهدف المتوسط
$78.57
+129,3%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
-0.19%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 31 مارس، 2026 | $-1.69 | $-1.35 | -0.34% |
| 31 ديسمبر، 2025 | $-1.39 | $-1.31 | -0.08% |
| 30 سبتمبر، 2025 | $-1.26 | $-1.16 | -0.10% |
| 30 يونيو، 2025 | $-1.20 | $-0.84 | -0.36% |
| 31 مارس، 2025 | $-0.81 | $-0.75 | -0.06% |
مقارنة النظراء المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| VERA | — | -10.9 | — | — | -55.9% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
| KOD | $1.73B | -6.5 | — | — | -202.0% | — |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 15
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $215M | $126M | $78M | $69M | $22M | $45M | |
| SG&A Expense | $100M | $41M | $24M | $22M | $12M | $4M | |
| Operating Expenses | $315M | $167M | $102M | $91M | $34M | $52M | |
| Operating Income | $-315M | $-167M | $-102M | $-91M | $-34M | $-52M | |
| Interest Expense | · | · | $4M | $992.0K | $20.0K | $166.0K | |
| Interest Income | $24M | $21M | $8M | $2M | $15.0K | $8.0K | |
| Other Non-op | $16M | $15M | $6M | $2M | $2M | $-1M | |
| Pretax Income | $-300M | $-152M | $-96M | $-89M | $-33M | $-53M | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $-1.0K | |
| Net Income | $-300M | $-152M | $-96M | $-89M | $-33M | $-53M | |
| EPS (Basic) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · | |
| EPS (Diluted) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · | |
| Shares (Basic) | 64,233,814 | 55,326,680 | 42,707,072 | 26,570,676 | 13,435,706 | · | |
| Shares (Diluted) | 64,233,814 | 55,326,680 | 42,707,072 | 26,570,676 | 13,435,706 | · | |
| EBITDA | $-315M | $-167M | $-106M | $-92M | $-34M | · |
الميزانية العمومية 20
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $355M | $93M | $46M | $43M | $80M | $54M | |
| Short-term Investments | $360M | $548M | $115M | $71M | $0 | · | |
| Prepaid Expense | $14M | $10M | $11M | $11M | $3M | $557.0K | |
| Other Current Assets | $3M | $1M | $2M | $719.0K | $480.0K | $392.0K | |
| Current Assets | $729M | $651M | $172M | $126M | $83M | $54M | |
| PP&E (Net) | $1M | $960.0K | $92.0K | $51.0K | $0 | · | |
| Other Non-current Assets | $6M | · | · | · | · | · | |
| Total Assets | $735M | $656M | $176M | $131M | $84M | $55M | |
| Accounts Payable | $22M | $8M | $11M | $12M | $1M | $909.0K | |
| Accrued Liabilities | $32M | $16M | $9M | $11M | $6M | $535.0K | |
| Current Liabilities | $53M | $25M | $22M | $26M | $8M | $2M | |
| Capital Leases | $2M | $2M | $1M | $4M | $0 | · | |
| Other Non-current Liabilities | $2M | · | · | · | · | · | |
| Total Liabilities | $130M | $79M | $74M | $55M | $14M | $4M | |
| Long-term Debt | $75M | $51M | $50M | $25M | $5M | $0 | |
| Common Stock | $71.0K | $64.0K | $44.0K | $28.0K | · | · | |
| Retained Earnings | $-761M | $-461M | $-309M | $-213M | $-124M | $-91M | |
| AOCI | $786.0K | $393.0K | $251.0K | $-224.0K | $0 | · | |
| Stockholders' Equity | $605M | $577M | $102M | $77M | $70M | $-89M | |
| Liabilities + Equity | $735M | $656M | $176M | $131M | $84M | $55M |
التدفق النقدي 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $468.0K | $105.0K | $21.0K | $-846.0K | $176.0K | $251.0K | |
| Stock-based Comp | $38M | $21M | $11M | $9M | $3M | $331.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | $0 | $3M | |
| Other Non-cash | $20M | $-3M | $-4M | $13M | $6M | · | |
| Operating Cash Flow | $-241M | $-135M | $-92M | $-68M | $-24M | $-35M | |
| CapEx | $630.0K | $972.0K | $63.0K | $62.0K | $0 | $99.0K | |
| Investing Cash Flow | $194M | $-425M | $-39M | $-71M | $-4M | $-42.0K | |
| Stock Issued | · | · | · | $2M | $0 | · | |
| Stock Repurchased | $0 | $13.0K | $0 | · | · | · | |
| Net Stock Activity | $0 | $-13.0K | · | $2M | $51M | · | |
| Financing Cash Flow | $309M | $607M | $134M | $102M | $54M | $85M | |
| Net Change in Cash | $262M | $47M | $2M | $-36M | $26M | $50M | |
| Taxes Paid | $17.0K | $1.0K | $1.0K | · | · | · | |
| Free Cash Flow | $-242M | $-136M | $-92M | $-68M | · | · | |
| Levered FCF | · | · | $-96M | $-69M | · | · |
الربحية 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -43.1% | -36.6% | -62.5% | -82.8% | -47.2% | · | |
| ROE | -55.9% | -35.1% | -85.2% | -97.5% | -42.1% | · | |
| ROIC | -52.2% | -29.0% | -100.3% | -118.2% | -49.4% | · |
السيولة والملاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 25.7 | 7.7 | 4.9 | 10.7 | · | |
| Quick Ratio | 13.4 | 25.3 | 7.2 | 4.5 | 10.4 | · | |
| Interest Coverage | · | · | -26.9 | -91.6 | -1720.1 | · |
التقييم (آخر 12 شهرًا) 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-300M | $-152M | $-96M | $-89M | $-33M | · | |
| P/E | -10.9 | -15.4 | -6.8 | -5.8 | -11.0 | · | |
| Earnings Yield | -9.2% | -6.5% | -14.6% | -17.3% | -9.1% | · |
قائمة الدخل 14
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $86M | $59M | $56M | $58M | $41M | $33M | $40M | $29M | $23M | $21M | $16M | $16M | $25M | $27M | $20M | $10M | |
| SG&A Expense | $39M | $35M | $27M | $22M | $16M | $16M | $9M | $8M | $8M | $6M | $6M | $6M | $6M | $7M | $6M | $5M | |
| Operating Expenses | $125M | $94M | $84M | $80M | $57M | $49M | $50M | $37M | $31M | $27M | $22M | $22M | $31M | $34M | $25M | $15M | |
| Operating Income | $-125M | $-94M | $-84M | $-80M | $-57M | $-49M | $-50M | $-37M | $-31M | $-27M | $-22M | $-22M | $-31M | $-34M | $-25M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $2M | · | $943.0K | $914.0K | $874.0K | $599.0K | $147.0K | $128.0K | |
| Interest Income | $6M | $6M | $6M | $6M | $7M | $7M | $5M | $5M | $4M | $2M | $2M | $2M | $2M | $894.0K | $567.0K | $263.0K | |
| Other Non-op | $4M | $3M | $4M | $4M | $6M | $5M | $3M | $4M | $3M | $1M | $2M | $2M | $1M | $1M | $565.0K | $204.0K | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $0 | $0 | |
| Net Income | $-121M | $-91M | $-80M | $-77M | $-52M | $-43M | $-47M | $-34M | $-28M | $-26M | $-20M | $-20M | $-30M | $-32M | $-25M | $-15M | |
| EPS (Basic) | $-1.69 | $-1.39 | $-1.26 | $-1.20 | $-0.81 | $-0.72 | $-0.85 | $-0.62 | $-0.56 | $-0.54 | $-0.45 | $-0.46 | $-0.80 | $-1.18 | $-0.91 | $-0.55 | |
| EPS (Diluted) | $-1.69 | $-1.39 | $-1.26 | $-1.20 | $-0.81 | $-0.72 | $-0.85 | $-0.62 | $-0.56 | $-0.54 | $-0.45 | $-0.46 | $-0.80 | $-1.18 | $-0.91 | $-0.55 | |
| Shares (Basic) | 71,476,595 | -127,074,102 | 63,847,055 | 63,789,303 | 63,671,558 | -105,272,102 | 54,898,297 | 54,728,552 | 50,971,933 | -83,593,685 | 44,363,419 | 44,269,772 | 37,667,566 | -51,950,930 | 27,215,874 | 27,078,450 | |
| Shares (Diluted) | 71,476,595 | -127,074,102 | 63,847,055 | 63,789,303 | 63,671,558 | -105,272,102 | 54,898,297 | 54,728,552 | 50,971,933 | -83,593,685 | 44,363,419 | 44,269,772 | 37,667,566 | -51,950,930 | 27,215,874 | 27,078,450 | |
| EBITDA | $-125M | · | $-84M | $-80M | $-57M | · | $-50M | $-37M | $-33M | · | $-22M | $-22M | $-32M | · | $-25M | $-15M |
الميزانية العمومية 20
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $114M | $355M | $58M | $49M | $55M | $93M | $27M | $25M | $69M | · | $27M | $34M | $137M | $43M | $30M | $50M | |
| Short-term Investments | $482M | $360M | $440M | $508M | $535M | $548M | $326M | $359M | $335M | · | $132M | $147M | $60M | $71M | $84M | $82M | |
| Prepaid Expense | $19M | $14M | $14M | $15M | $16M | $10M | $11M | $10M | $13M | · | $12M | $10M | $7M | $11M | $11M | $10M | |
| Other Current Assets | $2M | $3M | $1M | $2M | $2M | $1M | $1M | $429.0K | $568.0K | · | $2M | $1M | $883.0K | $719.0K | $792.0K | $776.0K | |
| Current Assets | $616M | $729M | $511M | $571M | $606M | $651M | $364M | $395M | $416M | · | $172M | $191M | $204M | $126M | $125M | $142M | |
| PP&E (Net) | $945.0K | $1M | $1M | $1M | $1M | $960.0K | $368.0K | $155.0K | $81.0K | · | $34.0K | $40.0K | $45.0K | $51.0K | $56.0K | $21.0K | |
| Other Non-current Assets | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $622M | $735M | $518M | $579M | $610M | $656M | $369M | $397M | $419M | · | $176M | $195M | $210M | $131M | $131M | $149M | |
| Accounts Payable | $14M | $22M | $18M | $13M | $9M | $8M | $5M | $5M | $5M | · | $12M | $13M | $5M | $12M | $7M | $7M | |
| Accrued Liabilities | $31M | $31M | $23M | $20M | $11M | $16M | $20M | $12M | $7M | · | $10M | $11M | $16M | $11M | $6M | $8M | |
| Current Liabilities | $45M | $53M | $42M | $34M | $22M | $25M | $26M | $18M | $15M | · | $25M | $27M | $24M | $26M | $16M | $17M | |
| Capital Leases | · | $2M | $2M | $2M | $2M | $2M | $3M | $455.0K | $919.0K | · | $2M | $3M | $3M | $4M | $4M | $5M | |
| Other Non-current Liabilities | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $122M | $130M | $119M | $110M | $75M | $79M | $80M | $69M | $66M | · | $52M | $55M | $52M | $55M | $26M | $27M | |
| Long-term Debt | $75M | $75M | $75M | $74M | $51M | $51M | $50M | $50M | $50M | · | $25M | $25M | $25M | $25M | $5M | $5M | |
| Common Stock | $72.0K | $71.0K | $64.0K | $64.0K | $64.0K | $64.0K | $55.0K | $55.0K | $54.0K | · | · | · | · | $28.0K | · | · | |
| Retained Earnings | $-882M | $-761M | $-670M | $-589M | $-513M | $-461M | $-418M | $-371M | $-337M | · | $-283M | $-263M | $-243M | $-213M | $-181M | $-156M | |
| AOCI | $-156.0K | $786.0K | $881.0K | $527.0K | $654.0K | $393.0K | $1M | $-450.0K | $-173.0K | · | $-75.0K | $-142.0K | $-4.0K | $-224.0K | $-279.0K | $-152.0K | |
| Stockholders' Equity | $500M | $605M | $399M | $468M | $535M | $577M | $289M | $328M | $354M | $102M | $124M | $141M | $158M | $77M | $106M | $122M | |
| Liabilities + Equity | $622M | $735M | $518M | $579M | $610M | $656M | $369M | $397M | $419M | · | $176M | $195M | $210M | $131M | $131M | $149M |
التدفق النقدي 10
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $140.0K | $135.0K | $129.0K | $119.0K | $85.0K | $55.0K | $24.0K | $1M | $11.0K | $4.0K | $1M | $517.0K | $-506.0K | $-597.0K | $-152.0K | $-106.0K | |
| Stock-based Comp | $13M | $11M | $10M | $9M | $8M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-cash | $1M | · | · | · | $-11M | · | · | · | $-8M | · | · | · | $2M | · | · | · | |
| Operating Cash Flow | $-106M | $-70M | $-62M | $-55M | $-54M | $-39M | $-37M | $-25M | $-34M | $-25M | $-23M | $-18M | $-26M | $-21M | $-18M | $-19M | |
| CapEx | $23.0K | $102.0K | $133.0K | $208.0K | $187.0K | $645.0K | $238.0K | $89.0K | $0 | $63.0K | $0 | $0 | $0 | $0 | $38.0K | $6.0K | |
| Investing Cash Flow | $-138M | $81M | $70M | $29M | $15M | $-221M | $38M | $-23M | $-219M | $19M | $16M | $-86M | $12M | $13M | $-2M | $-42M | |
| Stock Repurchased | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $286M | $797.0K | $20M | $2M | $326M | $739.0K | $3M | $277M | $25M | $297.0K | $432.0K | $108M | $21M | $908.0K | $48.0K | |
| Net Change in Cash | $-240M | $297M | $9M | $-6M | $-38M | $65M | $2M | $-44M | $23M | $18M | $-6M | $-104M | $94M | $13M | $-20M | $-61M | |
| Free Cash Flow | $-107M | · | · | · | $-55M | · | · | · | · | · | · | · | $-26M | · | · | · |
الربحية 2
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.7% | · | -18.1% | -15.7% | -10.0% | · | -17.1% | -11.4% | -9.0% | · | -13.1% | -11.7% | -16.1% | · | -22.2% | -12.0% | |
| ROE | -23.4% | · | -23.3% | -19.2% | -11.6% | · | -22.6% | -14.4% | -11.1% | · | -17.5% | -15.4% | -20.6% | · | -25.8% | -13.9% |
السيولة والملاءة 3
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | · | 12.2 | 17.0 | 27.7 | · | 13.8 | 21.4 | 28.6 | · | 7.0 | 7.1 | 8.7 | · | 7.9 | 8.2 | |
| Quick Ratio | 13.2 | · | 11.9 | 16.6 | 26.9 | · | 13.4 | 20.9 | 27.8 | · | 6.5 | 6.7 | 8.4 | · | 7.2 | 7.6 | |
| Interest Coverage | · | · | · | · | · | · | · | -19.5 | -16.3 | · | -23.1 | -24.0 | -35.8 | · | -171.7 | -117.6 |
التقييم (آخر 12 شهرًا) 3
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-330M | · | $-255M | $-209M | $-160M | · | $-129M | $-102M | $-99M | · | $-95M | $-90M | $-87M | · | $-64M | $-43M | |
| P/E | -8.1 | · | -7.1 | -6.8 | -8.5 | · | -17.8 | -17.3 | -19.0 | · | -5.2 | -5.9 | -2.6 | · | -8.4 | -7.0 | |
| Earnings Yield | -12.3% | · | -14.2% | -14.8% | -11.8% | · | -5.6% | -5.8% | -5.3% | · | -19.1% | -17.0% | -38.3% | · | -11.9% | -14.3% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| صافي الدخل | $-300M | $-152M | $-96M | $-89M | $-33M |
| EPS المخفف | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 13.6 | 25.7 | 7.7 | 4.9 | 10.7 |
| النسبة السريعة | 13.4 | 25.3 | 7.2 | 4.5 | 10.4 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $-242M | $-136M | $-92M | $-68M | — |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.